Medical Condition News

RSS

Survey finds fewer Americans use therapy to manage stress

Results of a recent survey reveal that, despite an increase in stress, fewer Americans use therapy as a way to manage it.

9 Nov 2009

Compugen discovers new biomarker for predisposition to type 2 diabetes using its GeneVa platform

Compugen Ltd. announced today the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of diabetes.

9 Nov 2009

ISTA Pharmaceuticals presents additional data from its Bepreve Phase 3 clinical studies

ISTA Pharmaceuticals, Inc., today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies. These results were presented in poster sessions at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Miami Beach, FL.

9 Nov 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

As the House of Representatives and the Senate debate companion bills to make health care more affordable and accessible, a coalition of obesity and public health experts today urged Congress not to overlook the needs of the more than 15 million Americans who suffer from severe obesity and are at the greatest risk for chronic disease and death.

9 Nov 2009

Tobacco smoke linked with respiratory diseases

Tobacco smoke is involved in uncontrolled asthma, a diminished response to anti-asthma drugs, rhinitis, nasal obstruction, and deregulation of the immune system according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.

9 Nov 2009

Women with asthma find it harder to sleep and feel more tired during the day than men

Women with asthma are more anxious, find it harder to sleep and are more tired during the day than their male counterparts, but nevertheless tend to be better at following their treatment, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg in close collaboration with Sahlgrenska University Hospital.

9 Nov 2009

$Connection between depression and loss of bone mass leads to osteoporosis and fractures$

Connection between depression and loss of bone mass leads to osteoporosis and fractures

Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.

9 Nov 2009

Pain management physician offers house calls to residents of Manhattan in New York City

Davis Bregman, a pain management physician will now offer routine house calls to residents of Manhattan in New York City. Patients will be able to request a house call by calling the office at 212-918-1629 or sending an email from davisbregman.com.

9 Nov 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

Cook Medical to feature a series of product demonstrations in Tokyo, Japan

In an ongoing effort to drive innovation in endourology, Cook Medical will feature a series of product demonstrations with a special emphasis on the PERC NCircle® Nitinol Tipless Stone Extractor, Flexor® Ureteral Access Sheath and the Ultraxx™ Nephrostomy Balloon at the 23rd Congress of the Japanese Society of Endourology and ESWL (extracorporeal shock wave lithotripsy), in Tokyo, Japan.

9 Nov 2009

Daval International receives award for its anti-inflammatory agent AIMSPRO

Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).

9 Nov 2009

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Most patients with hereditary angioedema (HAE) have prodromal symptoms that signal an oncoming HAE attack giving the patients sufficient time to initiate treatment and decrease the morbidity associated with that attack, according to survey findings presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting.

9 Nov 2009

Health Canada accepts for review the EpiCept’s New Drug Submission for Ceplene

EpiCept Corporation today announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.

9 Nov 2009

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Echosens, the French high-technology company specializing in non-invasive diagnostics in hepatology is the official sponsor of the Symposium held by Pr Sarin in the Famous Institute of liver and Biliary Sciences of New Delhi today. This symposium will focus on the non invasive diagnosis and management of hepatic fibrosis, with speakers from all around the world.

9 Nov 2009

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

An analysis demonstrating the ability of DX-88 (ecallantide) to resolve symptoms of acute hereditary angioedema (HAE) attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology (ACAAI) 2009 Annual Meeting in Miami Beach.

9 Nov 2009

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

Patients reported C1-esterase inhibitor (C1-INH) concentrate is an effective therapy in treating acute swelling attacks at any body location for HAE, a rare and serious genetic disorder, according to data presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting.

9 Nov 2009

LLS to participate in Gap's Give & Get program to support its blood cancer research

The Leukemia & Lymphoma Society (LLS) will again be participating in Gap Inc.'s Give & Get program, which in its first two campaigns this past spring and summer, garnered more than $1 million to support LLS's blood cancer research funding and patient education and support services.

7 Nov 2009

Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Registration is now open for the Society of Interventional Radiology's "Image-guided Interventional Oncology (IO) Therapies" Webinar, which will provide the latest updates on percutaneous and transcatheter treatment of liver tumors, kidney tumor ablation and lung tumor ablation.

7 Nov 2009

Study finds brain changes and severe depression in political detainees experiencing head injury

Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.

7 Nov 2009

Medical Condition News

Survey finds fewer Americans use therapy to manage stress

Compugen discovers new biomarker for predisposition to type 2 diabetes using its GeneVa platform

ISTA Pharmaceuticals presents additional data from its Bepreve Phase 3 clinical studies

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

Tobacco smoke linked with respiratory diseases

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

Women with asthma find it harder to sleep and feel more tired during the day than men

Connection between depression and loss of bone mass leads to osteoporosis and fractures

Pain management physician offers house calls to residents of Manhattan in New York City

Cellular mechanisms that may impact immune functions in the elderly discovered

Cook Medical to feature a series of product demonstrations in Tokyo, Japan

Daval International receives award for its anti-inflammatory agent AIMSPRO

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Health Canada accepts for review the EpiCept’s New Drug Submission for Ceplene

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

LLS to participate in Gap's Give & Get program to support its blood cancer research

Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Study finds brain changes and severe depression in political detainees experiencing head injury

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News